Aurora SK - Search Results

1

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.

Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group. Aurora SK, et al. Cephalalgia. 2010 Jul;30(7):793-803. doi: 10.1177/0333102410364676. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647170 Clinical Trial.

2

The threshold for phosphenes is lower in migraine.

Aurora SK, Welch KM, Al-Sayed F. Aurora SK, et al. Cephalalgia. 2003 May;23(4):258-63. doi: 10.1046/j.1468-2982.2003.00471.x. Cephalalgia. 2003. PMID: 12716342

3

Botulinum toxin type A for the treatment of migraine.

Aurora S. Aurora S. Expert Opin Pharmacother. 2006 Jun;7(8):1085-95. doi: 10.1517/14656566.7.8.1085. Expert Opin Pharmacother. 2006. PMID: 16722818 Review.

4

Gastric stasis occurs in spontaneous, visually induced, and interictal migraine.

Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Aurora S, et al. Headache. 2007 Nov-Dec;47(10):1443-6. doi: 10.1111/j.1526-4610.2007.00922.x. Epub 2007 Sep 12. Headache. 2007. PMID: 17868348

5

The brain is hyperexcitable in migraine.

Aurora SK, Wilkinson F. Aurora SK, et al. Cephalalgia. 2007 Dec;27(12):1442-53. doi: 10.1111/j.1468-2982.2007.01502.x. Cephalalgia. 2007. PMID: 18034688 Review.

6

Is chronic migraine one end of a spectrum of migraine or a separate entity?

Aurora SK. Aurora SK. Cephalalgia. 2009 Jun;29(6):597-605. doi: 10.1111/j.1468-2982.2008.01811.x. Epub 2009 Feb 18. Cephalalgia. 2009. PMID: 19228150 Review.

7

Topiramate modulates excitability of the occipital cortex when measured by transcranial magnetic stimulation.

Aurora SK, Barrodale PM, Vermaas AR, Rudra CB. Aurora SK, et al. Cephalalgia. 2010 Jun;30(6):648-54. doi: 10.1111/j.1468-2982.2009.01998.x. Epub 2010 Feb 11. Cephalalgia. 2010. PMID: 19732073

8

OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.

Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group. Diener HC, et al. Among authors: aurora sk. Cephalalgia. 2010 Jul;30(7):804-14. doi: 10.1177/0333102410364677. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647171 Clinical Trial.

9

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine.

Aurora S, Diener HC, Dodick D; PREEMPT Chronic Migraine Study Group. Aurora S, et al. J Headache Pain. 2011 Apr;12(2):137-8. doi: 10.1007/s10194-011-0334-4. Epub 2011 Apr 3. J Headache Pain. 2011. PMID: 21461938 Free PMC article. No abstract available.

10

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.

Lipton RB, Varon SF, Grosberg B, McAllister PJ, Freitag F, Aurora SK, Dodick DW, Silberstein SD, Diener HC, DeGryse RE, Nolan ME, Turkel CC. Lipton RB, et al. Among authors: aurora sk. Neurology. 2011 Oct 11;77(15):1465-72. doi: 10.1212/WNL.0b013e318232ab65. Epub 2011 Sep 28. Neurology. 2011. PMID: 21956721 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page